Allied Motion Reports 10% Revenue Growth and Record Backlog in 2021
Allied Motion Technologies reported a 10% year-over-year revenue growth, reaching $403.5 million in 2021, driven by industrial and vehicle markets recovering post-pandemic. The fourth quarter revenue was $96.8 million, up 4%. Gross margins improved to 30.0% for the year and 28.7% for Q4, despite supply chain challenges. Net income surged 77% to $24.1 million, or $1.66 per diluted share. The company completed three acquisitions, expecting an additional $60 million in revenue in 2022. Orders for Q4 totaled $114.9 million, leading to a backlog of $249.9 million.
- Revenue grew 10% to $403.5 million in 2021.
- Fourth quarter revenue increased 4% to $96.8 million.
- Gross margin improved to 30.0% for the year.
- Net income rose 77% to $24.1 million.
- Adjusted net income increased 26% to $1.26 per diluted share.
- Record backlog of $249.9 million, up 35% sequentially.
- Expecting approximately $60 million additional revenue from acquisitions in 2022.
- Fourth quarter sales in Vehicle markets declined by 12%.
- Aerospace and Defense markets sales dropped 19% due to program timing.
- Operating costs increased as a percentage of revenue to 24.5%.
-
Revenue grew
10% to in 2021, driven by broad-based recovery in target markets and new solutions offerings; Fourth quarter revenue was$403.5 million , up$96.8 million 4% from the prior year quarter -
Gross margin expanded 40 basis points to
30.0% in the year on higher volume, improved mix and strategic pricing; Fourth quarter gross margin was28.7% , up 80 basis points despite ongoing supply chain disruptions as well as material and labor inflation -
Annual net income increased
77% to , or$24.1 million per diluted share; Excluding net tax benefits and business development costs, adjusted net income was$1.66 per diluted share, up$1.26 26% for the year -
Fourth quarter orders of
drove a book-to-bill ratio of 1.2x$114.9 million -
Record backlog of
, up$249.9 million 35% sequentially on demand and incremental backlog from recent acquisitions -
Generated
of cash from operations in 2021$25.4 million - Completed three acquisitions in the fourth quarter that further enhance technology and capabilities
“Our results continue to demonstrate the successful execution of our strategic growth initiatives. For 2021, sales to our Industrial markets reached all-time highs and our Vehicle markets returned to pre-pandemic levels. Encouragingly, we also grew our Medical markets despite extremely tough comparisons from the prior year that saw significant demand for our products and solutions during the height of the pandemic,” commented
“As we look ahead to 2022 and beyond, our backlog and bookings remain robust, and we plan to continue to prudently invest to drive our organic growth engine while looking to further supplement our efforts with selective strategic acquisitions. Collectively, the three acquisitions at the end of 2021 are expected to provide incremental revenue of approximately
Fourth Quarter 2021 Results (Narrative compares with prior-year period unless otherwise noted)
Revenue increased
Sales to Industrial markets were up
Gross margin was
Operating costs and expenses as a percent of revenue were
Net income was
Earnings before interest, taxes, depreciation, amortization, stock-based compensation expense, business development costs, and foreign currency gains/losses (“Adjusted EBITDA”) was
Full Year 2021 Results (Narrative compares with prior-year period unless otherwise noted)
Revenue of
Gross margin of
Operating costs and expenses as a percent of revenue were
Net income was
Balance Sheet and Cash Flow Review
Cash and cash equivalents were
Total debt of
Orders and Backlog Summary ($ in thousands)
|
Q4 2021 |
Q3 2021 |
Q2 2021 |
Q1 2021 |
Q4 2020 |
||||||||||
Orders |
$ |
114,891 |
$ |
119,940 |
$ |
118,974 |
$ |
114,644 |
$ |
108,466 |
|||||
Backlog |
$ |
249,927 |
$ |
185,561 |
$ |
170,364 |
$ |
152,262 |
$ |
141,344 |
|||||
Orders of
Backlog increased
Conference Call and Webcast
The Company will host a conference call and webcast on
To listen to the live call, dial (201) 689-8263. In addition, the webcast and slide presentation may be found at: www.alliedmotion.com/investor-relations.
A telephonic replay will be available from
About
The Company’s growth strategy is focused on being the controlled motion solutions leader in its selected target markets by leveraging its “technology/know how” to develop integrated precision solutions that utilize multiple
Safe Harbor Statement
The statements in this news release and in the Company’s
FINANCIAL TABLES FOLLOW
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (In thousands, except per share data) (Unaudited) |
||||||||||||
For the three months ended |
For the year ended |
|||||||||||
|
|
|
||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|||||
Revenue |
$ |
96,793 |
$ |
92,998 |
$ |
403,516 |
$ |
366,694 |
||||
Cost of goods sold |
|
69,043 |
|
67,065 |
|
282,460 |
|
258,119 |
||||
Gross profit |
|
27,750 |
|
25,933 |
|
121,056 |
|
108,575 |
||||
Operating costs and expenses: |
||||||||||||
Selling |
|
4,270 |
|
3,573 |
|
17,249 |
|
15,392 |
||||
General and administrative |
|
9,870 |
|
9,421 |
|
42,419 |
|
38,301 |
||||
Engineering and development |
|
6,851 |
|
6,622 |
|
27,818 |
|
25,487 |
||||
Business development |
|
1,031 |
|
41 |
|
1,299 |
|
473 |
||||
Amortization of intangible assets |
|
1,718 |
|
1,505 |
|
6,245 |
|
5,928 |
||||
Total operating costs and expenses |
|
23,740 |
|
21,162 |
|
95,030 |
|
85,581 |
||||
Operating income |
|
4,010 |
|
4,771 |
|
26,026 |
|
22,994 |
||||
Other expense, net: |
||||||||||||
Interest expense |
|
791 |
|
917 |
|
3,236 |
|
3,716 |
||||
Other (income) expense, net |
|
(165) |
|
195 |
|
(323) |
|
502 |
||||
Total other expense, net |
|
626 |
|
1,112 |
|
2,913 |
|
4,218 |
||||
Income before income taxes |
|
3,384 |
|
3,659 |
|
23,113 |
|
18,776 |
||||
Income tax (provision) benefit |
|
(1,823) |
|
(960) |
|
981 |
|
(5,133) |
||||
Net income |
$ |
1,561 |
$ |
2,699 |
$ |
24,094 |
$ |
13,643 |
||||
Basic earnings per share: |
||||||||||||
Earnings per share |
$ |
0.11 |
$ |
0.19 |
$ |
1.67 |
$ |
0.96 |
||||
Basic weighted average common shares |
|
14,527 |
|
14,279 |
|
14,413 |
|
14,243 |
||||
Diluted earnings per share: |
||||||||||||
Earnings per share |
$ |
0.11 |
$ |
0.19 |
$ |
1.66 |
$ |
0.95 |
||||
Diluted weighted average common shares |
|
14,632 |
|
14,403 |
|
14,517 |
|
14,333 |
||||
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except per share data) |
||||||
|
|
|
|
|
|
|
|
|
|
||||
|
|
2021 |
|
2020 |
||
Assets |
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
22,463 |
|
$ |
23,131 |
Trade receivables, net of provision for credit losses of |
|
|
51,239 |
|
|
47,377 |
Inventories |
|
|
89,733 |
|
|
62,978 |
Prepaid expenses and other assets |
|
|
12,522 |
|
|
8,728 |
Total current assets |
|
|
175,957 |
|
|
142,214 |
Property, plant and equipment, net |
|
|
56,983 |
|
|
55,428 |
Deferred income taxes |
|
|
5,321 |
|
|
330 |
Intangible assets, net |
|
|
103,786 |
|
|
65,859 |
|
|
|
106,633 |
|
|
61,860 |
Right of use assets |
|
|
16,983 |
|
|
19,023 |
Other long-term assets |
|
|
5,122 |
|
|
4,483 |
Total Assets |
|
$ |
470,785 |
|
$ |
349,197 |
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
Accounts payable |
|
$ |
36,714 |
|
$ |
27,668 |
Accrued liabilities |
|
|
41,656 |
|
|
24,862 |
Total current liabilities |
|
|
78,370 |
|
|
52,530 |
Long-term debt |
|
|
158,960 |
|
|
120,079 |
Deferred income taxes |
|
|
5,040 |
|
|
4,659 |
Pension and post-retirement obligations |
|
|
3,932 |
|
|
5,340 |
Right of use liabilities |
|
|
12,792 |
|
|
14,975 |
Other long-term liabilities |
|
|
23,929 |
|
|
8,558 |
Total liabilities |
|
|
283,023 |
|
|
206,141 |
Stockholders’ Equity: |
|
|
|
|
|
|
Common stock, no par value, authorized 50,000 shares; 15,361 and 14,632 shares issued and outstanding at |
|
|
68,097 |
|
|
41,278 |
Preferred stock, par value |
|
|
— |
|
|
— |
Retained earnings |
|
|
127,757 |
|
|
105,065 |
Accumulated other comprehensive loss |
|
|
(8,092) |
|
|
(3,287) |
Total stockholders’ equity |
|
|
187,762 |
|
|
143,056 |
Total Liabilities and Stockholders’ Equity |
|
$ |
470,785 |
|
$ |
349,197 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) |
||||||
|
|
|
|
|
|
|
|
|
For the year ended |
||||
|
|
|
|
|
||
|
|
2021 |
|
2020 |
||
Cash Flows From Operating Activities: |
|
|
|
|
|
|
Net income |
|
$ |
24,094 |
|
$ |
13,643 |
Adjustments to reconcile net income to net cash provided by operating activities |
|
|
|
|
|
|
Depreciation and amortization |
|
|
18,107 |
|
|
15,985 |
Deferred income taxes |
|
|
(6,135) |
|
|
(519) |
Provision for excess and obsolete inventory |
|
|
534 |
|
|
1,106 |
Provision for warranty |
|
|
543 |
|
|
34 |
Debt issue cost amortization recorded in interest expense |
|
|
141 |
|
|
144 |
Restricted stock compensation |
|
|
4,161 |
|
|
3,550 |
Other |
|
|
(128) |
|
|
(333) |
Changes in operating assets and liabilities, net of acquisitions: |
|
|
|
|
|
|
Trade receivables |
|
|
(170) |
|
|
2,711 |
Inventories |
|
|
(22,874) |
|
|
(4,686) |
Prepaid expenses and other assets |
|
|
(3,670) |
|
|
(2,264) |
Accounts payable |
|
|
8,293 |
|
|
(1,874) |
Accrued liabilities |
|
|
2,506 |
|
|
(2,659) |
Net cash provided by operating activities |
|
|
25,402 |
|
|
24,838 |
|
|
|
|
|
|
|
Cash Flows From Investing Activities: |
|
|
|
|
|
|
Consideration paid for acquisitions, net of cash acquired |
|
|
(47,254) |
|
|
(14,728) |
Purchase of property and equipment |
|
|
(13,716) |
|
|
(9,371) |
Net cash used in investing activities |
|
|
(60,970) |
|
|
(24,099) |
|
|
|
|
|
|
|
Cash Flows From Financing Activities: |
|
|
|
|
|
|
Principal payments of long-term debt |
|
|
(12,248) |
|
|
(16,897) |
Proceeds from issuance of long-term debt |
|
|
51,379 |
|
|
26,979 |
Payment of debt issuance costs |
|
|
— |
|
|
(401) |
Dividends paid to stockholders |
|
|
(1,371) |
|
|
(1,160) |
Tax withholdings related to net share settlements of restricted stock |
|
|
(1,928) |
|
|
(1,032) |
Net cash provided by financing activities |
|
|
35,832 |
|
|
7,489 |
Effect of foreign exchange rate changes on cash |
|
|
(932) |
|
|
1,487 |
Net (decrease) increase in cash and cash equivalents |
|
|
(668) |
|
|
9,715 |
Cash and cash equivalents at beginning of period |
|
|
23,131 |
|
|
13,416 |
Cash and cash equivalents at end of period |
|
$ |
22,463 |
|
$ |
23,131 |
|
|
|
|
|
|
|
Reconciliation of Non-GAAP Financial Measures
(In thousands)
(Unaudited)
In addition to reporting revenue and net income, which are
The Company believes that Revenue excluding foreign currency exchange rate impacts is a useful measure in analyzing organic sales results. The Company excludes the effect of currency translation from revenue for this measure because currency translation is not under management’s control, is subject to volatility and can obscure underlying business trends. The portion of revenue attributable to currency translation is calculated as the difference between the current period revenue and the current period revenue after applying foreign exchange rates from the prior period.
The Company believes EBITDA and Adjusted EBITDA are often a useful measure of a Company’s operating performance and are a significant basis used by the Company’s management to evaluate and compare the core operating performance of its business from period to period by removing the impact of the capital structure (interest), tangible and intangible asset base (depreciation and amortization), taxes, stock-based compensation expense, business development costs, foreign currency gains/losses on short-term assets and liabilities, and other items that are not indicative of the Company’s core operating performance. EBITDA and Adjusted EBITDA do not represent and should not be considered as an alternative to net income, operating income, net cash provided by operating activities or any other measure for determining operating performance or liquidity that is calculated in accordance with GAAP.
The Company’s calculation of Revenue excluding foreign currency exchange impacts for the three and twelve months ended
Three Months Ended |
|
Twelve Months Ended |
||||
|
|
|
||||
Revenue as reported |
$ |
96,793 |
|
$ |
403,516 |
|
Currency impact |
|
859 |
|
|
(8,332) |
|
Revenue excluding foreign currency exchange impacts |
$ |
97,652 |
|
$ |
395,184 |
|
The Company’s calculation of Adjusted EBITDA for the three and twelve months ended
Three Months Ended
|
Twelve Months Ended
|
|||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||
Net income |
$ |
1,561 |
$ |
2,699 |
$ |
24,094 |
$ |
13,643 |
||||
Interest expense |
|
791 |
|
917 |
|
3,236 |
|
3,716 |
||||
Provision (benefit) for income tax |
|
1,823 |
|
960 |
|
(981) |
|
5,133 |
||||
Depreciation and amortization |
|
4,790 |
|
4,303 |
|
18,107 |
|
15,985 |
||||
EBITDA |
|
8,965 |
|
8,879 |
|
44,456 |
|
38,477 |
||||
Stock compensation expense |
|
1,061 |
|
910 |
|
4,161 |
|
3,550 |
||||
Foreign currency loss |
|
63 |
|
542 |
|
21 |
|
1,035 |
||||
Business development costs |
|
1,031 |
|
42 |
|
1,299 |
|
473 |
||||
Non-income based tax assessment |
|
- |
|
(424) |
|
- |
|
(424) |
||||
Adjusted EBITDA |
$ |
11,120 |
$ |
9,948 |
$ |
49,937 |
$ |
43,111 |
||||
Reconciliation of GAAP Net Income and Diluted Earnings per Share to
Non-GAAP Adjusted Net Income and Diluted Earnings per Share
(In thousands, except per share data)
(Unaudited)
The Company’s calculation of Adjusted net income and Adjusted diluted earnings per share for the three and twelve months ended
Three Months Ended |
Twelve Months Ended |
||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||
2021 |
Per diluted share |
2020 |
Per diluted share |
2021 |
Per diluted share |
2020 |
Per diluted share |
||||||||||||||||||||
Net income as reported |
$ |
1,561 |
$ |
0.11 |
$ |
2,699 |
$ |
0.19 |
$ |
24,094 |
$ |
1.66 |
$ |
13,643 |
$ |
0.95 |
|||||||||||
Non-GAAP adjustments, net of tax |
|||||||||||||||||||||||||||
Discrete income tax benefit |
|
|
- |
|
- |
|
|
- |
|
- |
|
|
(7,373) |
|
(0.51) |
|
|
- |
|
- |
|||||||
Non-income based tax assessment |
|
|
- |
|
- |
|
|
(424) |
|
(0.03) |
|
|
- |
|
- |
|
|
(424) |
|
(0.03) |
|||||||
Income tax valuation allowance |
|
|
506 |
|
0.03 |
|
|
- |
|
- |
|
|
506 |
|
0.03 |
|
|
- |
|
- |
|||||||
Foreign currency loss |
|
|
48 |
|
- |
|
|
400 |
|
0.03 |
|
|
16 |
|
- |
|
|
752 |
|
0.05 |
|||||||
Business development costs |
|
790 |
|
0.05 |
|
30 |
|
- |
|
995 |
|
0.07 |
|
344 |
|
0.02 |
|||||||||||
Adjusted net income and diluted EPS |
$ |
2,905 |
$ |
0.20 |
$ |
2,705 |
$ |
0.19 |
$ |
18,238 |
$ |
1.26 |
$ |
14,315 |
$ |
1.00 |
|||||||||||
Weighted average diluted shares outstanding |
|
|
14,632 |
|
14,403 |
|
|
14,517 |
|
|
14,333 |
||||||||||||||||
Adjusted net income and diluted EPS are defined as net income as reported, adjusted for unusual non-recurring items. Adjusted net income and diluted EPS are not a measure determined in accordance with GAAP in
View source version on businesswire.com: https://www.businesswire.com/news/home/20220309005919/en/
Investor Contact:
Phone: 716-843-3908
Email: dpawlowski@keiadvisors.com
Source:
FAQ
What were Allied Motion Technologies' 2021 revenue figures?
How much did Allied Motion Technologies' net income increase in 2021?
What was the book-to-bill ratio for Allied Motion Technologies in Q4 2021?
What is the expected revenue from recent acquisitions in 2022?